Package 11673-651-78

Brand: naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 11673-651-78
Digits Only 1167365178
Product NDC 11673-651
Product ID 11673-651_45723671-6285-3bb2-e063-6294a90ab0b8
Description

1 BOTTLE, PLASTIC in 1 CARTON (11673-651-78) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2025-12-08
Brand naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

Naproxen Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45723671-6285-3bb2-e063-6294a90ab0b8", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["1112231"], "spl_set_id": ["36bf8594-9303-c816-e063-6294a90af705"], "manufacturer_name": ["TARGET Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (11673-651-78)  / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC", "package_ndc": "11673-651-78", "marketing_start_date": "20251208"}], "brand_name": "Naproxen Sodium", "product_id": "11673-651_45723671-6285-3bb2-e063-6294a90ab0b8", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "11673-651", "generic_name": "Naproxen Sodium", "labeler_name": "TARGET Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "NDA021920", "marketing_category": "NDA", "marketing_start_date": "20251208", "listing_expiration_date": "20261231"}